Pharmacokinetics, efficacy and safety profiles of preserved and preservative-free tafluprost in healthy volunteers

Uusitalo H., Kaarniranta K., Ropo A.

2008
Acta Ophthalmologica

View publication

Therapeutic Area

Glaucoma
Technology

Pharmacology
Categories

Clinical development

Affiliations

Department of Ophthalmology, University of Kuopio, Kuopio, Finland; Department of Ophthalmology, Tampere University Hospital, University of Tampere, 33014 Tampereen, Yliopisto, Finland; Department of Clinical Research, Santen Oy, Helsinki, Finland

Related Publications

Effects of French maritime pine bark/bilberry fruit extracts on intraocular pressure for primary open-angle glaucoma

Manabe K., Kaidzu S., Tsutsui A., Mochiji M., Matsuoka Y., Takagi Y., Miyamoto E., Tanito M.

Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial

Wang T.H.; Aung T.; Lu D.-W.; George R.; Senthil S.; Lu F.; Odani-Kawabata N.; Park K.H.

Efficacy and Safety of a Preservative-Free Latanoprost Cationic Emulsion in Patients with Open-Angle Glaucoma and Concurrent Ocular Surface Disease: A Randomized Phase 2 Study.

Bacharach, Jason; McLaurin, Eugene B.; Silverstein, Steven; Amrane, Mourad; Garrigue, Jean-Sebastien; Ismail, Dahlia; Flynn, William J.; Catiolanze Phase 2 study group

View all Glaucoma publications